XML 27 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 5 - Investments
3 Months Ended
Mar. 31, 2018
Investments [Abstract]  
Investments
Investments
Available for Sale Securities
Our available for sale securities within our investment portfolio consisted of the following as of the dates indicated:
 
March 31, 2018
(In thousands)
Amortized
Cost
 
Fair Value
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
Fixed-maturities available for sale:
 
 
 
 
 
 
 
U.S. government and agency securities
$
65,278

 
$
63,656

(1)
$

 
$
1,622

State and municipal obligations
157,176

 
159,329

 
3,882

 
1,729

Corporate bonds and notes
1,910,482

 
1,881,117

 
10,525

 
39,890

RMBS
233,144

 
228,040

(2)
128

 
5,232

CMBS
476,601

 
470,834

 
1,085

 
6,852

Other ABS
736,967

 
736,518

 
1,819

 
2,268

Foreign government and agency securities
32,412

 
32,396

 
257

 
273

Total fixed-maturities available for sale
$
3,612,060

 
$
3,571,890

(3)
$
17,696

 
$
57,866


______________________
(1)
Includes securities with a fair value of $4.8 million serving as collateral for FHLB advances.
(2)
Includes securities with a fair value of $23.3 million serving as collateral for FHLB advances.
(3)
Includes $17.2 million of fixed maturity securities loaned to third-party Borrowers under securities lending agreements, classified as other assets in our condensed consolidated balance sheets, as further described below.
 
December 31, 2017
(In thousands)
Amortized
Cost
 
Fair Value
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
Fixed-maturities available for sale:
 
 
 
 
 
 
 
U.S. government and agency securities
$
69,667

 
$
69,396

 
$
96

 
$
367

State and municipal obligations
156,587

 
161,722

 
5,834

 
699

Corporate bonds and notes
1,869,318

 
1,894,886

 
33,620

 
8,052

RMBS
189,455

 
187,229

 
636

 
2,862

CMBS
451,595

 
453,394

 
3,409

 
1,610

Other ABS
672,715

 
674,548

 
2,655

 
822

Foreign government and agency securities
31,417

 
32,207

 
823

 
33

Total fixed-maturities available for sale
3,440,754

 
3,473,382

(1)
47,073

 
14,445

Equity securities available for sale (2) 
176,349

 
176,065

(1)
1,705

 
1,989

Total debt and equity securities
$
3,617,103

 
$
3,649,447

 
$
48,778

 
$
16,434

______________________
(1)
Includes $14.7 million of fixed maturity securities and $13.2 million of equity securities loaned to third-party Borrowers under securities lending agreements, classified as other assets in our condensed consolidated balance sheets, as further described below.
(2)
Primarily consists of investments in fixed-income and equity exchange-traded funds and publicly-traded business development company equities.
Gross Unrealized Losses and Fair Value of Available for Sale Securities
For securities deemed “available for sale” and that are in an unrealized loss position, the following tables show the gross unrealized losses and fair values, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, as of the dates indicated. Included in the amounts as of March 31, 2018 and December 31, 2017, are loaned securities under securities lending agreements that are classified as other assets in our condensed consolidated balance sheets, as further described below.
 
March 31, 2018
($ in thousands) Description of Securities
Less Than 12 Months
 
12 Months or Greater
 
Total
# of
securities
 
Fair Value
 
Unrealized
Losses
 
# of
securities
 
Fair Value
 
Unrealized
Losses
 
# of
securities
 
Fair Value
 
Unrealized
Losses
U.S. government and agency securities
7

 
$
41,246

 
$
1,116

 
3

 
$
9,520

 
$
506

 
10

 
$
50,766

 
$
1,622

State and municipal obligations
28

 
79,897

 
1,729

 

 

 

 
28

 
79,897

 
1,729

Corporate bonds and notes
344

 
1,348,488

 
32,623

 
28

 
127,265

 
7,267

 
372

 
1,475,753

 
39,890

RMBS
20

 
112,041

 
1,606

 
27

 
79,087

 
3,626

 
47

 
191,128

 
5,232

CMBS
67

 
375,353

 
6,592

 
5

 
2,814

 
260

 
72

 
378,167

 
6,852

Other ABS
127

 
439,883

 
2,228

 
5

 
4,649

 
40

 
132

 
444,532

 
2,268

Foreign government and agency securities
19

 
20,800

 
273

 

 

 

 
19

 
20,800

 
273

Total
612

 
$
2,417,708

 
$
46,167

 
68

 
$
223,335

 
$
11,699

 
680

 
$
2,641,043

 
$
57,866

 
December 31, 2017
($ in thousands) Description of Securities
Less Than 12 Months
 
12 Months or Greater
 
Total
# of
securities
 
Fair Value
 
Unrealized
Losses
 
# of
securities
 
Fair Value
 
Unrealized
Losses
 
# of
securities
 
Fair Value
 
Unrealized
Losses
U.S. government and agency securities
6

 
$
23,309

 
$
129

 
3

 
$
9,799

 
$
238

 
9

 
$
33,108

 
$
367

State and municipal obligations
21

 
65,898

 
699

 

 

 

 
21

 
65,898

 
699

Corporate bonds and notes
152

 
672,318

 
4,601

 
32

 
139,105

 
3,451

 
184

 
811,423

 
8,052

RMBS
8

 
19,943

 
204

 
26

 
101,812

 
2,658

 
34

 
121,755

 
2,862

CMBS
35

 
139,353

 
1,395

 
4

 
3,518

 
215

 
39

 
142,871

 
1,610

Other ABS
92

 
260,864

 
777

 
7

 
8,297

 
45

 
99

 
269,161

 
822

Foreign government and agency securities
5

 
7,397

 
33

 

 

 

 
5

 
7,397

 
33

Equity securities
13

 
149,785

 
1,989

 

 

 

 
13

 
149,785

 
1,989

Total
332

 
$
1,338,867

 
$
9,827

 
72

 
$
262,531

 
$
6,607

 
404

 
$
1,601,398

 
$
16,434


Impairments due to credit deterioration that result in a conclusion that the present value of cash flows expected to be collected will not be sufficient to recover the amortized cost basis of the security are considered other-than-temporary. Other declines in fair value (for example, due to interest rate changes, sector credit rating changes or company-specific rating changes) that result in a conclusion that the present value of cash flows expected to be collected will not be sufficient to recover the amortized cost basis of the security also may serve as a basis to conclude that an other-than-temporary impairment has occurred. To the extent we determine that a security is deemed to have had an other-than-temporary impairment, an impairment loss is recognized.
During the three months ended March 31, 2018, we recorded other-than-temporary impairment losses in earnings of $0.9 million due to our intent to sell certain corporate and state and municipal bonds at a loss. For the year ended December 31, 2017, we recorded other-than-temporary impairment losses in earnings of $1.4 million. These losses comprised $0.4 million recorded due to our intent to sell certain corporate bonds at a loss and $1.0 million recorded due to credit deterioration, which included $0.5 million related to a convertible note of a non-public company issuer included in debt securities and $0.5 million related to a privately-placed equity security. There were no credit-related impairment losses recognized in accumulated other comprehensive income (loss) during the three months ended March 31, 2018 or year ended December 31, 2017.
Although we held securities in an unrealized loss position as of March 31, 2018, we did not consider those securities to be other-than-temporarily impaired as of such date. For all investment categories, the unrealized losses of 12 months or greater duration as of March 31, 2018 were generally caused by interest rate or credit spread movements since the purchase date, and as such, we expect the present value of cash flows to be collected from these securities to be sufficient to recover the amortized cost basis of these securities. As of March 31, 2018, we did not have the intent to sell any debt securities in an unrealized loss position, and we determined that it is more likely than not that we will not be required to sell the securities before recovery of their cost basis, which may be at maturity; therefore, we did not consider these investments to be other-than-temporarily impaired at March 31, 2018.
Trading Securities
The trading securities within our investment portfolio, which are recorded at fair value, consisted of the following as of the dates indicated:
(In thousands)
March 31,
2018
 
December 31,
2017
Trading securities:
 
 
 
State and municipal obligations
$
203,188

 
$
214,841

Corporate bonds and notes
280,323

 
307,271

RMBS
26,084

 
29,520

CMBS
49,634

 
50,561

Foreign government and agency securities
4,180

 
4,241

Total (1) 
$
563,409

 
$
606,434

______________________
(1)
Includes a de minimis amount of loaned securities under securities lending agreements that are classified as other assets in our consolidated balance sheets, as further described below.
For trading securities held at March 31, 2018, we had net unrealized losses associated with those securities of $11.4 million during the three months ended March 31, 2018, compared to net unrealized gains of $3.5 million for the three months ended March 31, 2017. For equity securities held at March 31, 2018, we had net losses of $1.8 million during the three months ended March 31, 2018. Prior to the implementation of the update to the standard for the accounting of financial instruments effective January 1, 2018, the unrealized losses associated with equity securities were classified in accumulated other comprehensive income.
For the three months ended March 31, 2018, we did not transfer any securities from the available for sale or trading categories.
Securities Lending Agreements
During the third quarter of 2017, we commenced participation in a securities lending program whereby we loan certain securities in our investment portfolio to Borrowers for short periods of time. These securities lending agreements are collateralized financing arrangements whereby we transfer securities to third parties through an intermediary in exchange for cash or other securities. In all of our securities lending agreements, the securities we transfer to Borrowers (loaned securities) may be transferred or loaned by the Borrowers; however, we maintain effective control over all loaned securities, including: (i) retaining ownership of the securities; (ii) receiving the related investment or other income; and (iii) having the right to request the return of the loaned securities at any time. Although we report such securities at fair value within other assets in our condensed consolidated balance sheets, the detailed information regarding investments provided in this Note includes these securities.
Under our securities lending agreements, the Borrower is required to provide to us collateral, consisting of cash or securities, in amounts generally equal to or exceeding (i) 102% of the value of the loaned securities (105% in the case of foreign securities) or (ii) another agreed-upon percentage not less than 100% of the market value of the loaned securities. Any cash collateral we receive may be invested in liquid assets.
The Borrower generally may return the loaned securities to us at any time, which would require us to return the collateral within the standard settlement period for the loaned securities on the principal exchange or market in which the securities are traded. We manage this liquidity risk associated with cash collateral by maintaining the cash collateral in a short-term money-market fund with daily availability. The credit risk under these programs is reduced by the amounts of collateral received. On a daily basis, the value of the underlying securities that we have loaned to the Borrowers is compared to the value of cash and securities collateral we received from the Borrowers, and additional cash or securities are requested or returned, as applicable. In addition, we are indemnified against counterparty credit risk by the intermediary.
Key components of our securities lending agreements at March 31, 2018 and December 31, 2017 consisted of the following:
(In thousands)
March 31,
2018
 
December 31,
2017
Loaned securities (1):
 
 
 
U.S. government and agency securities
$
975

 
$

Corporate bonds and notes
15,508

 
13,862

Foreign government and agency securities
904

 
867

Equity securities
27,009

 
13,235

Total loaned securities, at fair value
$
44,396

 
$
27,964

 
 
 
 
Total loaned securities, at amortized cost
$
45,266

 
$
27,846

Securities collateral on deposit from Borrowers (2) 
6,345

 
9,342

Reinvested cash collateral, at estimated fair value (3) 
39,077

 
19,357

______________________
(1)
Our securities loaned under securities lending agreements are reported at fair value within other assets in our condensed consolidated balance sheets. All of our securities lending agreements are classified as overnight and revolving. None of the amounts are subject to offsetting.
(2)
Securities collateral on deposit with us from Borrowers may not be transferred or re-pledged unless the Borrower is in default, and is therefore not reflected in our condensed consolidated financial statements.
(3)
All cash collateral received has been reinvested in accordance with the securities lending agreements and is included in short-term investments in our condensed consolidated balance sheets. Amounts payable on the return of cash collateral under securities lending agreements are included within other liabilities in our condensed consolidated balance sheets.
Net Gains (Losses) on Investments and Other Financial Instruments
Net realized and unrealized gains (losses) on investments and other financial instruments consisted of:
 
Three Months Ended March 31,
(In thousands)
2018
 
2017
Net realized gains (losses):
 
 
 
Fixed-maturities available for sale
$
(3,120
)
 
$
(2,509
)
Equity securities
142

 

Trading securities
(538
)
 
(5,694
)
Short-term investments

 
6

Other invested assets
62

 

Other gains (losses)
12

 
18

Net realized gains (losses) on investments
(3,442
)
 
(8,179
)
Other-than-temporary impairment losses
(844
)
 

Unrealized gains (losses) on investment securities (1) 
(12,804
)
 
5,226

Total net gains (losses) on investments
(17,090
)
 
(2,953
)
Net gains (losses) on other financial instruments
(1,797
)
 
102

Net gains (losses) on investments and other financial instruments
$
(18,887
)
 
$
(2,851
)

______________________
(1)
These amounts include unrealized gains (losses) on investment securities other than securities available for sale. For the three months ended March 31, 2017, the amount excludes the net change in unrealized gains and losses on equity securities. Prior to the implementation of the update to the standard for the accounting of financial instruments effective January 1, 2018, the unrealized losses associated with equity securities were classified in accumulated other comprehensive income.
Contractual Maturities
The contractual maturities of fixed-maturity investments available for sale were as follows:
 
March 31, 2018
 
Available for Sale
(In thousands)
Amortized
Cost
 
Fair
Value
Due in one year or less (1) 
$
35,241

 
$
35,146

Due after one year through five years (1) 
745,894

 
735,622

Due after five years through 10 years (1) 
1,016,043

 
989,756

Due after 10 years (1) 
368,170

 
375,974

RMBS (2) 
233,144

 
228,040

CMBS (2) 
476,601

 
470,834

Other ABS (2) 
736,967

 
736,518

Total (3) 
$
3,612,060

 
$
3,571,890

______________________
(1)
Actual maturities may differ as a result of calls before scheduled maturity.
(2)
RMBS, CMBS and Other ABS are shown separately, as they are not due at a single maturity date.
(3)
Includes securities loaned under securities lending agreements.
Other
At March 31, 2018, Radian had an aggregate amount of $28.1 million of U.S. government and agency securities and RMBS, classified as fixed-maturities available for sale within our investment securities portfolio, serving as collateral for our FHLB advances. There were no FHLB advances outstanding at December 31, 2017. See Note 12 for additional information.
Securities on deposit with various state insurance commissioners amounted to $14.9 million and $11.8 million at March 31, 2018 and December 31, 2017, respectively.